- Record: found
- Abstract: not found
- Article: not found
A second large trial of Telmisartan and HCTZ (80/25 mg) shows a larger antihypertensive effect than Valsartan and HCTZ (160/25 mg)
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.